PCRX PACIRA BIOSCIENCES INC

Ownership history in Jump Financial, LLC  ·  10 quarters on record

This page tracks every 13F SEC filing in which Jump Financial, LLC reported a position in PACIRA BIOSCIENCES INC (PCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.14% (2021 Q2)
Avg. % of fund
0.05%
First filed
2021 Q2
Last filed
2025 Q3
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 20,458 -132,151 -86.6% 0.01% $527K $25.77
2024 Q3 ADDED 152,609 +140,309 +1140.7% 0.05% $2.3M $15.05
2024 Q2 REDUCED 12,300 -27,969 -69.5% 0.01% $352K $28.61
2024 Q1 ADDED 40,269 +969 +2.5% 0.03% $1.2M $29.22
2023 Q4 REDUCED 39,300 -19,573 -33.2% 0.04% $1.3M $33.74
2023 Q3 ADDED 58,873 +47,173 +403.2% 0.07% $1.8M $30.68
2023 Q2 REDUCED 11,700 -23,682 -66.9% 0.02% $469K $40.07
2022 Q4 ADDED 35,382 +28,919 +447.5% 0.07% $1.4M $38.61
2021 Q4 REDUCED 6,463 -18,222 -73.8% 0.02% $389K $60.17
2021 Q2 INITIATED 24,685 0.14% $1.5M $60.68
% of Fund (quarterly)    PCRX price (monthly, adj. close)
← Back to Jump Financial, LLC Holdings